Ghent University Academic Bibliography

Your filters: cql: author="Barbieri, Eveline" or (type any "bookEditor issueEditor" and editor="Barbieri, Eveline")

Add to list
- Journal Article
- A2
- open access
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation

Alan Van Goethem (UGent) , Jill Deleu (UGent) , Nurten Yigit (UGent) , Celine Everaert (UGent) , Myrthala Moreno-Smith, Sanjeev A Vasudevan, Fjoralba Zeka (UGent) , Fleur Demuynck (UGent) , Eveline Barbieri, Franki Speleman (UGent) , et al.

(2023) NAR CANCER. 5(1).
Add to list
Longitudinal evaluation of murine serum microRNAs as biomarkers for neuroblastoma burden and therapeutic TP53 reactivation

Alan Van Goethem (UGent) , Nurten Yigit (UGent) , Celine Everaert (UGent) , Myrthala Moreno-Smith, Sanjeev A Vasudevan, Fjoralba Zeka (UGent) , Fleur Demunck, Eveline Barbieri, Franki Speleman (UGent) , Pieter Mestdagh (UGent) , et al.

(2018) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
Circulating microRNA biomarkers for metastatic neuroblastoma

Fjoralba Zeka (UGent) , Alan Van Goethem (UGent) , Tim Lammens (UGent) , Anneleen Decock (UGent) , Hetty Helsmoortel (UGent) , Genevieve Laureys (UGent) , Michael Hogarty, Eveline Barbieri, Jason Shohet, Frank Berthold, et al.

(2018) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

Fjoralba Zeka (UGent) , Anneleen Decock (UGent) , Alan Van Goethem (UGent) , Katrien Vanderheyden, Fleur Demuynck (UGent) , Tim Lammens (UGent) , Hetty Helsmoortel (UGent) , Joëlle Vermeulen, Rosa Noguera, Ana P. Berbegall, et al.

(2018) JCI INSIGHT. 3(23).
Add to list
- Journal Article
- A1
- open access
Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma

Alan Van Goethem (UGent) , Nurten Yigit (UGent) , Myrthala Moreno-Smith, Sanjeev A Vasudevan, Eveline Barbieri, Franki Speleman (UGent) , Jason Shohet, Jo Vandesompele (UGent) and Tom Van Maerken (UGent)

(2017) ONCOTARGET. 8(34). p.57047-57057
Add to list
- Journal Article
- A1
- open access
Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples

Alan Van Goethem (UGent) , Nurten Yigit (UGent) , Celine Everaert (UGent) , Myrthala Moreno-Smith, Liselot Mus (UGent) , Eveline Barbieri, Franki Speleman (UGent) , Pieter Mestdagh (UGent) , Jason Shohet, Tom Van Maerken (UGent) , et al.

(2016) SCIENTIFIC REPORTS. 6.
Add to list
- Conference Paper
- C3
Identification of non-invasive biomarkers for treatment response in neuroblastoma by circulating miRNA profiling

Alan Van Goethem (UGent) , Nurten Yigit (UGent) , Mythala Moreno-Smith, Celine Everaert (UGent) , Olivier Delattre, Pieter Mestdagh (UGent) , Saurabh Agarwal, Eveline Barbieri, Isabelle Janoueix-Lerosey, Jason Shohet, et al.

(2016) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma

Eveline Barbieri, Katleen De Preter (UGent) , Mario Capasso, Zaowen Chen, Danielle M Hsu, Gian Paolo Tonini, Steve Lefever (UGent) , John Hicks, Rogier Versteeg, Andrea Pession, et al.

(2014) CANCER RESEARCH. 74(3). p.765-774
Add to list
- Journal Article
- A1
- open access
A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma

Eveline Barbieri, Katleen De Preter (UGent) , Mario Capasso, Peter Johansson, Tsz-Kwong Man, Zaowen Chen, Paris Stowers, Gian Paolo Tonini, Franki Speleman (UGent) and Jason M Shohet

(2013) PLOS ONE. 8(11).
Add to list
A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma

Jason M Shohet, Rajib Ghosh, Cristian Coarfa, Andrew Ludwig, Ashley L Benham, ZaoWen Chen, Danielle M Patterson, Eveline Barbieri, Pieter Mestdagh (UGent) , Denae N Sikorski, et al.

(2011) CANCER RESEARCH. 71(11). p.3841-3851

Academic Bibliography

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation

Longitudinal evaluation of murine serum microRNAs as biomarkers for neuroblastoma burden and therapeutic TP53 reactivation

Circulating microRNA biomarkers for metastatic neuroblastoma

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma

Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples

Identification of non-invasive biomarkers for treatment response in neuroblastoma by circulating miRNA profiling

Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma

A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma

A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma

Contents

Support

Contact